| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |